Liver cancer is often deadly—less than 20% of patients survive five years—and it’s the leading cause of cancer-related deaths worldwide. And things aren’t getting better. Between the prevalence of hepatitis C and an escalating rate of obesity that leads to fatty liver disease and potentially cancer, new treatments are desperately needed for these cancer patients. Continue reading “Blocking RANTES may slow growth of liver cancer”